Zoetis Inc (ZTS) - Total Liabilities
Based on the latest financial reports, Zoetis Inc (ZTS) has total liabilities worth $9.76 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Zoetis Inc (ZTS) equity growth momentum to track the company's year-over-year net asset growth rate.
Zoetis Inc - Total Liabilities Trend (2010–2024)
This chart illustrates how Zoetis Inc's total liabilities have evolved over time, based on quarterly financial data. See ZTS cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Zoetis Inc Competitors by Total Liabilities
The table below lists competitors of Zoetis Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TESCO PLC ADR/1 LS-05
F:TCO2
|
Germany | €28.71 Billion |
|
Chunghwa Telecom Co
TW:2412
|
Taiwan | NT$135.08 Billion |
|
Saab AB (publ)
ST:SAAB-B
|
Sweden | Skr81.03 Billion |
|
JD.com Inc Adr
F:013A
|
Germany | €401.42 Billion |
|
PTT Public Company Limited
BK:PTT
|
Thailand | ฿1.62 Trillion |
|
Steel Dynamics Inc
NASDAQ:STLD
|
USA | $7.59 Billion |
|
Naspers Limited
F:NNWN
|
Germany | €24.55 Billion |
|
KERING.UNSP.ADR 1/10 EO 4
F:PPXB
|
Germany | €25.67 Billion |
Liability Composition Analysis (2010–2024)
This chart breaks down Zoetis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zoetis Inc (ZTS) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zoetis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zoetis Inc (2010–2024)
The table below shows the annual total liabilities of Zoetis Inc from 2010 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.47 Billion | +1.85% |
| 2023-12-31 | $9.29 Billion | -11.66% |
| 2022-12-31 | $10.52 Billion | +12.46% |
| 2021-12-31 | $9.36 Billion | -4.88% |
| 2020-12-31 | $9.84 Billion | +11.30% |
| 2019-12-31 | $8.84 Billion | +2.85% |
| 2018-12-31 | $8.59 Billion | +26.35% |
| 2017-12-31 | $6.80 Billion | +10.57% |
| 2016-12-31 | $6.15 Billion | -9.85% |
| 2015-12-31 | $6.82 Billion | +29.92% |
| 2014-12-31 | $5.25 Billion | -6.17% |
| 2013-12-31 | $5.60 Billion | +151.96% |
| 2012-12-31 | $2.22 Billion | +12.46% |
| 2011-12-31 | $1.98 Billion | +1.80% |
| 2010-12-31 | $1.94 Billion | -- |
About Zoetis Inc
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and… Read more